Narcolepsy

• Safety, tolerability, and efficacy of alixorexton, a selective orexin 2 receptor agonist for narcolepsy type 1 (Vibrance-1): a randomised, double-blind, placebo-controlled, phase 2 trial

  2026 The Lancet Neurology article Neuroscience Sleep and Wakefulness Research

  0

  citations
• Effects of Oveporexton, an Orexin Receptor 2–Selective Agonist, on Cognition in Narcolepsy Type 1

  2025 JAMA Neurology article Neuroscience Sleep and Wakefulness Research Open access

  11

  citations
• Oveporexton, an Oral Orexin Receptor 2–Selective Agonist, in Narcolepsy Type 1

  2025 New England Journal of Medicine article Neuroscience Sleep and Wakefulness Research

  63

  citations
• Recent insights into the pathophysiology of narcolepsy type 1

  2024 Sleep Medicine Reviews article Neuroscience Sleep and Wakefulness Research Open access

  13

  citations
• Barriers to therapy adherence in narcolepsy

  2024 Sleep Medicine article Medicine Medication Adherence and Compliance Open access

  10

  citations
• Sleep-Related Hallucinations

  2023 Sleep Medicine Clinics article Neuroscience Hallucinations in medical conditions Open access

  9

  citations
• Complementary and alternative medicine use in narcolepsy

  2023 Sleep Medicine article Medicine Complementary and Alternative Medicine Studies Open access

  6

  citations

7 results